March 6, 2019
Congratulations to Dr. Nicholas Brady, a post-doctoral fellow working in David Rickman’s lab, who won 1st prize for a poster and talk he presented at the 12th Annual Multi-Institutional Prostate Cancer SPORE Retreat.Nicholas is also a recipient of the NIH/NCI Molecular and Translational Oncology Research (MTOR) Training Program (7/2018 – 6/2020).
February 17, 2019
We are delighted to announce that the New York City Chapter of The Leukemia & Lymphoma Society (LLS) will be honoring Dr. Selina Chen-Kiang at the 2nd Annual Crimson Ball on Wednesday, April 24, 2019 at The Mandarin Oriental in New York City
February 17, 2019
It is with great pleasure that I announce the appointment of David P. Hajjar, Ph.D. as Executive Vice Chair of Pathology and Laboratory Medicine, effective immediately.
December 9, 2018
Weill Cornell Medicine has been awarded a five-year, $9 million Program Project Grant (P01) from the National Cancer Institute (NCI) to better understand how and why patients with an aggressive and incurable form of lymphoma initially respond to treatment, only to relapse over time. The findings may enable investigators to develop superior therapies that are effective, well tolerated and tailored to individual patients with mantle cell lymphoma.
November 26, 2018
November 13, 2018
NEW YORK (November 13, 2018)—Dr. Massimo Loda, an internationally renowned molecular pathologist, has been appointed chair of the Department of Pathology and Laboratory Medicine at Weill Cornell Medicine and pathologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective Feb. 1.
September 24, 2018
Congratulations to Selina Chen-Kiang, PhD, for being awarded an NCI Program Project Grant from NIH/NCI entitled: Mechanism-Based Targeting of Mantle Cell Lymphoma. The total federal award amount is in excess of $9 million dollars for five years.
June 13, 2018
The Department is pleased to announce the appointment of...
May 22, 2018
A molecule promoting blood vessel growth in bone can create an environment suitable for bone-building formation, representing a potential target for new drugs to treat osteoporosis and fractures, according to new research by Weill Cornell Medicine scientists.
April 4, 2018
Congratulations to Dr. Daniel Knowles for being selected to receive the Distinguished Service Award of the Medical and Biological Sciences Alumni Association of the University of Chicago.